# VIREON Architecture — V1.0

VIREON is an evidence-aware monitoring platform prototype composed of replaceable domain modules.

System flow:
Synthetic sources -> Event ingestion/validation -> Persistent event store -> Signal engine / AI-GUARD / Digital measures -> Evidence graph -> Trial integrity + Lifecycle engine -> Human review.

## Module contracts
- Event boundary: typed, timezone-aware input validation.
- Signal engine: deterministic, versioned rules.
- Evidence graph: event -> signal -> evidence relationships.
- AI-GUARD: reference/current distribution and missingness monitoring.
- Digital measures: completeness and expected-range checks.
- Trial integrity: site-level monitoring indicators for missingness, deviations, and timestamp collisions.
- Lifecycle engine: discovery through post-market workflow representation.

## Design rationale
FDA/EMA's January 2026 AI principles emphasize human-centric design, risk-based assessment, context of use, data governance/documentation, model lifecycle management, and performance assessment. FDA is also expanding digital-health and real-time-clinical-trial work. VIREON converts those themes into explicit, testable software boundaries.

## Non-goals
No diagnosis, treatment recommendation, autonomous clinical decision, regulatory approval prediction, patient data, or claim of regulatory compliance.
